|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12345678910111213...3940» |
- | Enrollment closed, Enrollment change: RRFT: Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD (clinicaltrials.gov) - Jan 11, 2018
P=N/A, N=135, Active, not recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting | N=250 --> 135
- | naltrexone / Generic mfg.
Trial completion, Enrollment change: Employment-Based Depot Naltrexone Clinical Trial (clinicaltrials.gov) - Dec 26, 2017
P2, N=35, Completed, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | N=250 --> 135 Recruiting --> Completed | N=80 --> 35
- | Biomarker, New trial: MAW Phase 2: Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2 (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=39, Completed, Sponsor: Mayo Clinic
- | New trial: Evaluating Vocational Materials for Incarcerated Veterans With Mental Illness or Substance Abuse (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=111, Completed, Sponsor: VA Office of Research and Development
- | naltrexone / Generic mfg.
New P2 trial, Combination therapy: Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana (clinicaltrials.gov) - Dec 19, 2017
P2, N=49, Completed, Sponsor: New York State Psychiatric Institute
- | dextroamphetamine immediate release / Generic mfg.
New P2 trial: Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo (clinicaltrials.gov) - Dec 19, 2017
P2, N=186, Completed, Sponsor: The University of Texas Health Science Center, Houston
- | naltrexone / Generic mfg.
Trial completion, Combination therapy: Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana (clinicaltrials.gov) - Dec 19, 2017
P2, N=49, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed | N=80 --> 35 Not yet recruiting --> Completed
- | dextroamphetamine immediate release / Generic mfg.
Trial completion: Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo (clinicaltrials.gov) - Dec 19, 2017
P2, N=186, Completed, Sponsor: The University of Texas Health Science Center, Houston
Not yet recruiting --> Completed Recruiting --> Completed
- | Enrollment change: Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers (clinicaltrials.gov) - Dec 19, 2017
P2, N=34, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed N=26 --> 34
- | NN1213 / Novo Nordisk
Phase classification, Enrollment change: Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=148, Completed, Sponsor: Johns Hopkins University
N=26 --> 34 Phase classification: P3 --> P=N/A | N=387 --> 148
- | Trial completion: Evaluating Vocational Materials for Incarcerated Veterans With Mental Illness or Substance Abuse (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=111, Completed, Sponsor: VA Office of Research and Development
Phase classification: P3 --> P=N/A | N=387 --> 148 Active, not recruiting --> Completed
- | dextroamphetamine immediate release / Generic mfg.
Enrollment change: Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo (clinicaltrials.gov) - Dec 19, 2017
P2, N=186, Completed, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Completed N=140 --> 186
- | Biomarker, Trial completion: Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=150, Completed, Sponsor: Mayo Clinic
N=140 --> 186 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women (clinicaltrials.gov) - Dec 5, 2017
P=N/A, N=148, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Recruiting --> Completed
- | naltrexone / Generic mfg.
Trial completion, Phase classification, Trial primary completion date: Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) (clinicaltrials.gov) - Nov 30, 2017
P4, N=75, Completed, Sponsor: University of Michigan
Recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: May 2019 --> Dec 2015
- | midazolam hydrochloride / Generic mfg.
Enrollment change, Trial termination: Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: Study Comparing Midazolam and Propofol With Midazolam (clinicaltrials.gov) - Nov 28, 2017
P=N/A, N=11, Terminated, Sponsor: Yonsei University
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: May 2019 --> Dec 2015 N=56 --> 11 | Recruiting --> Terminated; because of difficulties for participants enrollment
- | Trial completion, Enrollment change: Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=28, Completed, Sponsor: Institute of Liver and Biliary Sciences, India
N=56 --> 11 | Recruiting --> Terminated; because of difficulties for participants enrollment Recruiting --> Completed | N=56 --> 28
- | Phase classification: Intensive Intervention for Smokers - 6 (clinicaltrials.gov) - Nov 1, 2017
P=N/A, N=162, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=56 --> 28 Phase classification: P2/3 --> P=N/A
- | Trial primary completion date: Cannabidiol: a Novel Intervention for Cannabis Use Problems? (clinicaltrials.gov) - Oct 27, 2017
P2a, N=168, Active, not recruiting, Sponsor: University College, London
Phase classification: P2/3 --> P=N/A Trial primary completion date: Jul 2017 --> Jul 2018
- | Trial completion, Trial primary completion date: Delivery of Anxiety Disorder Treatment in Addictions Centers (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=98, Completed, Sponsor: University of California, Los Angeles
Trial primary completion date: Jul 2017 --> Jul 2018 Active, not recruiting --> Completed | Trial primary completion date: Oct 2017 --> Nov 2016
- | Trial completion, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=150, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed | Trial primary completion date: Oct 2017 --> Nov 2016 Active, not recruiting --> Completed
- | acetylcysteine solution / Generic mfg.
Trial completion: Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC) (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=16, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed Recruiting --> Completed
- | sertraline / Generic mfg.
Trial primary completion date: Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 (clinicaltrials.gov) - Oct 25, 2017
P2, N=9, Terminated, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed Trial primary completion date: Dec 2009 --> Dec 2005
- | Trial primary completion date: Testing a Promising Treatment for Youth Substance Abuse in a Community Setting (clinicaltrials.gov) - Oct 24, 2017
P1/2, N=204, Recruiting, Sponsor: Medical University of South Carolina
Trial primary completion date: Dec 2009 --> Dec 2005 Trial primary completion date: Jul 2017 --> May 2018
- | Trial primary completion date: The Effectiveness of rTMS in Depressed VA Patients (clinicaltrials.gov) - Oct 17, 2017
P3, N=164, Completed, Sponsor: VA Office of Research and Development
Trial primary completion date: Jul 2017 --> May 2018 Trial primary completion date: Feb 2016 --> Feb 2017
- | Trial completion, Trial initiation date: Phase II Motivational Interviewing: An Experiential Online Training Tool (clinicaltrials.gov) - Oct 16, 2017
P2, N=3816, Completed, Sponsor: Center for Social Innovation, Massachusetts
Trial primary completion date: Feb 2016 --> Feb 2017 Recruiting --> Completed | Initiation date: Mar 2016 --> Aug 2016
- | Enrollment closed, Enrollment change, Trial primary completion date: Family and Adolescent Motivational Incentives for Leveraging Youth (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=212, Active, not recruiting, Sponsor: Oregon Research Institute
Recruiting --> Completed | Initiation date: Mar 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=160 --> 212 | Trial primary completion date: Apr 2017 --> Apr 2018
- | Trial primary completion date: The Effectiveness of rTMS in Depressed VA Patients (clinicaltrials.gov) - Oct 7, 2017
P3, N=164, Completed, Sponsor: VA Office of Research and Development
Recruiting --> Active, not recruiting | N=160 --> 212 | Trial primary completion date: Apr 2017 --> Apr 2018 Trial primary completion date: Feb 2017 --> Feb 2016
- | Trial completion, Trial initiation date: Telephone-Based Continuing Care for Alcohol Dependence (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=317, Completed, Sponsor: University of Bern
Trial primary completion date: Feb 2017 --> Feb 2016 Active, not recruiting --> Completed | Initiation date: Jul 2013 --> Dec 2013
- | Enrollment closed, Enrollment change: Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy (clinicaltrials.gov) - Oct 6, 2017
P1, N=60, Active, not recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed | Initiation date: Jul 2013 --> Dec 2013 Recruiting --> Active, not recruiting | N=80 --> 60
- | Trial completion: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (clinicaltrials.gov) - Oct 2, 2017
P1, N=73, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting | N=80 --> 60 Recruiting --> Completed
- | Trial completion: Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=1000, Completed, Sponsor: University of Southern Denmark
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: PC: Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=312, Completed, Sponsor: RAND
Recruiting --> Completed Active, not recruiting --> Completed
- | methamphetamine / Generic mfg., mirtazapine / Generic mfg.
Enrollment closed: Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0) (clinicaltrials.gov) - Sep 25, 2017
P2, N=120, Active, not recruiting, Sponsor: Phillip Coffin, MD, MIA
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Sep 18, 2017
P3, N=566, Completed, Sponsor: Butler Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Enrollment change, Adherence: Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy (clinicaltrials.gov) - Sep 12, 2017
P=N/A, N=9, Completed, Sponsor: AiCure
Active, not recruiting --> Completed Not yet recruiting --> Completed | N=75 --> 9
- | buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Trial completion, Enrollment change: Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance (clinicaltrials.gov) - Sep 11, 2017
P1, N=132, Completed, Sponsor: Johns Hopkins University
Not yet recruiting --> Completed | N=75 --> 9 Recruiting --> Completed | N=100 --> 132
- GET 73 / CT Pharmaceutical Laboratory
Trial primary completion date: SPAD: Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (clinicaltrials.gov) - Sep 5, 2017
P1b/2a, N=25, Recruiting, Sponsor: Laboratorio Farmaceutico Ct S.r.l.
Recruiting --> Completed | N=100 --> 132 Trial primary completion date: Feb 2017 --> Nov 2017
- | Trial completion, IO biomarker: Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction (clinicaltrials.gov) - Sep 1, 2017
P=N/A, N=30, Completed, Sponsor: University of Nebraska
Trial primary completion date: Feb 2017 --> Nov 2017 Recruiting --> Completed
- | Trial completion, Trial primary completion date: Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence (clinicaltrials.gov) - Aug 29, 2017
P1, N=11, Completed, Sponsor: Rajesh Narendran
Recruiting --> Completed Terminated --> Completed | Trial primary completion date: Dec 2015 --> Oct 2013
- | Trial completion, Trial primary completion date: RESC: Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms. (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=43, Completed, Sponsor: Hospices Civils de Lyon
Terminated --> Completed | Trial primary completion date: Dec 2015 --> Oct 2013 Not yet recruiting --> Completed | Trial primary completion date: May 2015 --> Nov 2016
- | quetiapine / Generic mfg.
Trial completion, Trial primary completion date: QUEST: Quetiapine Pharmacotherapy for Cannabis Dependence (clinicaltrials.gov) - Aug 22, 2017
P2, N=130, Completed, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Completed | Trial primary completion date: May 2015 --> Nov 2016 Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016
- | Trial completion: Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=60, Completed, Sponsor: University of Washington
Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016 Active, not recruiting --> Completed
- | ondansetron / Generic mfg.
Trial completion, Trial primary completion date: Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults (clinicaltrials.gov) - Aug 21, 2017
P2, N=300, Completed, Sponsor: Bankole A. Johnson
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Sep 2016
- | Enrollment closed, Enrollment change, Trial initiation date: OPAL: "Opiates and PhArmacoLogy" (clinicaltrials.gov) - Aug 11, 2017
P=N/A, N=263, Active, not recruiting, Sponsor: Nantes University Hospital
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Sep 2016 Recruiting --> Active, not recruiting | N=354 --> 263 | Initiation date: Jan 2014 --> Jul 2013
- | Trial completion, Enrollment change, Trial primary completion date: Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults (clinicaltrials.gov) - Aug 10, 2017
P3, N=25, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Active, not recruiting | N=354 --> 263 | Initiation date: Jan 2014 --> Jul 2013 Active, not recruiting --> Completed | N=75 --> 25 | Trial primary completion date: Jan 2015 --> Feb 2005
- | Trial termination: The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence (clinicaltrials.gov) - Aug 8, 2017
P1/2, N=55, Terminated, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed | N=75 --> 25 | Trial primary completion date: Jan 2015 --> Feb 2005 Recruiting --> Terminated; An analysis demonstrated that running the final participants was unnecessary.
- | amphetamine/dextroamphetamine immediate release tablet / Generic mfg., topiramate / Generic mfg.
Trial completion: TACT2: Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (clinicaltrials.gov) - Aug 8, 2017
P2/3, N=168, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Terminated; An analysis demonstrated that running the final participants was unnecessary. Active, not recruiting --> Completed
- | baclofen / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: BacALD: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease (clinicaltrials.gov) - Aug 8, 2017
P3, N=104, Completed, Sponsor: South West Sydney Local Health District
Active, not recruiting --> Completed Recruiting --> Completed | N=180 --> 104 | Trial primary completion date: Aug 2015 --> Jun 2017
- | dronabinol oral / Generic mfg.
Trial completion: The Effect of Prescription Medications in Marijuana Users (clinicaltrials.gov) - Aug 3, 2017
P1/2, N=24, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed | N=180 --> 104 | Trial primary completion date: Aug 2015 --> Jun 2017 Recruiting --> Completed